Filing Flows › DexCom (DXCM) › Q1 2025
DexCom (DXCM) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
DexCom (DXCM) reported revenue of $1.0B for the first quarter 2025 (Q1 2025), +12% from a year earlier and -7% from the quarter before. Operating margin was 12.9%, net earnings $105M (10.2% of revenue).
DexCom, Q1 2025: revenue $1.0B (+12% year over year), operating margin 12.9%, net earnings $105M, operating cash flow $184M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0B | -7% | +12% |
| Gross profit | $589M | -10% | +5% |
| Operating profit | $134M | -29% | +32% |
| Net earnings | $105M | -31% | -28% |
| Operating cash flow | $184M | -39% | -12% |
| Free cash flow | $96.8M | -45% | -36% |
What changed
Revenue was $1.0B in Q1 2025, up 12% year over year and down 7% from the previous quarter.
Gross margin was 56.9%, down 4.2 points from a year earlier. Operating profit was $0.13B, a 12.9% margin (up 1.9 points year over year). Of the extra revenue versus a year earlier, 28% reached operating profit, above the 11% margin then. Operating expenses fell 1% while revenue rose 12%. Net earnings were $0.11B, down 28% year over year. The effective tax rate was 31.7%.
Operating cash flow was $0.18B (down 12% year over year), 174% of net earnings. Non-cash charges added back $0.06B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items used $0.02B. Capital expenditures of $0.09B left free cash flow of $0.10B.
Questions
What was DexCom's revenue in the first quarter 2025?
DexCom (DXCM) reported revenue of $1.0B for the first quarter 2025 (Q1 2025), +12% from a year earlier and -7% from the quarter before.
Was DexCom profitable in the first quarter 2025?
Operating profit was $134M (12.9% of revenue) and net earnings $105M.
Source: DexCom 10-Q on SEC EDGAR.